Company Filing History:
Years Active: 2023
Title: Jaclyn Ho: Innovator in Gene Therapy
Introduction
Jaclyn Ho is a prominent inventor based in San Mateo, CA (US). She has made significant contributions to the field of gene therapy, particularly in the treatment of heart diseases. Her innovative work focuses on developing methods and compositions that can potentially transform patient care in cardiology.
Latest Patents
Jaclyn Ho holds a patent for "Plakophillin-2 gene therapy methods and compositions." This patent outlines methods and compositions for plakophilin-2 gene therapy aimed at treating heart diseases such as arrhythmogenic right ventricular cardiomyopathy (ARVC) and arrhythmogenic cardiomyopathy (ACM). This groundbreaking work has the potential to improve the lives of many patients suffering from these conditions.
Career Highlights
Jaclyn is currently associated with Tenaya Therapeutics, Inc., where she continues to advance her research in gene therapy. Her dedication to innovation in the medical field is evident through her focused efforts on developing effective treatments for heart diseases.
Collaborations
Jaclyn collaborates with esteemed colleagues, including Zhihong Jane Yang and Chris Reid. These partnerships enhance her research and contribute to the advancement of gene therapy techniques.
Conclusion
Jaclyn Ho is a trailblazer in the field of gene therapy, with her work holding promise for the treatment of serious heart conditions. Her contributions are paving the way for future innovations in medical science.